• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺病毒介导的p53基因转染人膀胱癌细胞系:细胞毒性及与顺铂的协同作用

Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin.

作者信息

Pagliaro Lance C, Keyhani Afsaneh, Liu Baoshun, Perrotte Paul, Wilson Deborah, Dinney Colin P

机构信息

Department of Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

出版信息

Urol Oncol. 2003 Nov-Dec;21(6):456-62. doi: 10.1016/s1078-1439(03)00032-2.

DOI:10.1016/s1078-1439(03)00032-2
PMID:14693272
Abstract

Mutations of the tumor suppressor gene p53 are common in bladder cancer. To determine whether p53 gene transfer would lead to decreased viability of bladder cancer cells, we studied the effect of p53 gene transfer in human bladder cancer cell lines with either mutant or wild-type p53. Bladder cancer cell lines 5637 and J82 (which express only mutant p53) and 253J-BV (which expresses wild-type p53) were transduced with vectors containing the beta-galactosidase gene (Ad5-lacZ), wild-type human p53 gene (Ad5CMV-p53), or no foreign gene (DL312 or Ad5-polyA). X-gal staining of cells exposed to Ad5-lacZ showed that the adenoviral vector was capable of transducing each of the cell lines. Increases in p53, p21(waf1/cip1) and bax protein were demonstrated following exposure to Ad5CMV-p53, and there was a dose-dependent increase in the number of apoptotic cells. Cell viability was decreased in all three cell lines, although J82 was less sensitive than either 5637 or 253J-BV. To determine whether cisplatin increases sensitivity of J82 cells to Ad5CMV-p53, we performed median effect analysis for cisplatin combined with Ad5CMV-p53 or DL312. The combination index for cisplatin plus Ad5CMV-p53 revealed synergy, whereas cisplatin and DL312 were only additive. These results suggest that forced p53 gene expression is cytotoxic to human bladder cancer cells with either p53 mutant or wild-type background, and that combination with cisplatin is a potential method for overcoming resistance.

摘要

肿瘤抑制基因p53的突变在膀胱癌中很常见。为了确定p53基因转移是否会导致膀胱癌细胞活力下降,我们研究了p53基因转移对具有突变型或野生型p53的人膀胱癌细胞系的影响。用含有β-半乳糖苷酶基因(Ad5-lacZ)、野生型人p53基因(Ad5CMV-p53)或无外源基因(DL312或Ad5-polyA)的载体转导膀胱癌细胞系5637和J82(仅表达突变型p53)以及253J-BV(表达野生型p53)。对暴露于Ad5-lacZ的细胞进行X-gal染色表明腺病毒载体能够转导每个细胞系。暴露于Ad5CMV-p53后,p53、p21(waf1/cip1)和bax蛋白增加,并且凋亡细胞数量呈剂量依赖性增加。所有三个细胞系的细胞活力均下降,尽管J82比5637或253J-BV敏感性低。为了确定顺铂是否会增加J82细胞对Ad5CMV-p53的敏感性,我们对顺铂与Ad5CMV-p53或DL312联合进行了中位效应分析。顺铂加Ad5CMV-p53的联合指数显示协同作用,而顺铂和DL312仅为相加作用。这些结果表明,强制p53基因表达对具有p53突变或野生型背景的人膀胱癌细胞具有细胞毒性,并且与顺铂联合是克服耐药性的一种潜在方法。

相似文献

1
Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin.腺病毒介导的p53基因转染人膀胱癌细胞系:细胞毒性及与顺铂的协同作用
Urol Oncol. 2003 Nov-Dec;21(6):456-62. doi: 10.1016/s1078-1439(03)00032-2.
2
Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.在人膀胱癌模型中,通过联合使用靶向聚集素基因的反义寡脱氧核苷酸,腺病毒介导的p53基因转移的治疗效果得到协同增强。
Neoplasia. 2005 Feb;7(2):171-9. doi: 10.1593/neo.04478.
3
Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.在人乳腺癌细胞系中,腺病毒介导的Ad5CMVp53和Ad5CMVp21基因治疗与标准疗法联合应用。
Ann Clin Lab Sci. 2000 Oct;30(4):395-405.
4
Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.顺铂化疗联合腺病毒p53基因治疗EBV阳性和阴性鼻咽癌。
Cancer Gene Ther. 2001 May;8(5):352-60. doi: 10.1038/sj.cgt.7700319.
5
Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.腺病毒介导的p53基因递送增强野生型p53人胶质瘤细胞的放射敏感性
J Neurosurg. 1998 Jul;89(1):125-32. doi: 10.3171/jns.1998.89.1.0125.
6
Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer model.腺病毒介导的P53基因转移在人膀胱癌模型中对肿瘤生长和转移的协同化学增敏作用及抑制作用
Urology. 2000 Aug 1;56(2):332-6. doi: 10.1016/s0090-4295(00)00567-7.
7
Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer.腺病毒介导的p53基因转染增强人膀胱癌细胞的化学敏感性
Anticancer Res. 1998 Jul-Aug;18(4C):3087-92.
8
Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer.膀胱癌细胞中Bcl-2的过表达可抑制顺铂诱导的凋亡以及腺病毒介导的p53基因转移所诱导的凋亡。
Oncogene. 1998 Feb 19;16(7):933-43. doi: 10.1038/sj.onc.1201602.
9
The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma.电离辐射与腺病毒p53疗法联合治疗鼻咽癌的效果。
Int J Radiat Oncol Biol Phys. 1999 Feb 1;43(3):607-16. doi: 10.1016/s0360-3016(98)00432-5.
10
Additional gene therapy with rAAV-wt-p53 enhanced the efficacy of cisplatin in human bladder cancer cells.用重组腺相关病毒野生型p53进行的额外基因治疗增强了顺铂在人膀胱癌细胞中的疗效。
Urol Int. 2006;77(4):355-61. doi: 10.1159/000096341.

引用本文的文献

1
Unlocking the potential: advancements and applications of gene therapy in severe disorders.释放潜能:基因疗法在严重疾病中的进展与应用
Ann Med. 2025 Dec;57(1):2516697. doi: 10.1080/07853890.2025.2516697. Epub 2025 Jun 17.
2
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy.从血液系统恶性肿瘤中p53的调控到去调控:对诊断、预后和治疗的影响
Biomark Res. 2024 Nov 14;12(1):137. doi: 10.1186/s40364-024-00676-9.
3
Downregulation of topoisomerase 1 and 2 with acriflavine sensitizes bladder cancer cells to cisplatin-based chemotherapy.
吖啶黄下调拓扑异构酶1和2可使膀胱癌细胞对顺铂化疗敏感。
Mol Biol Rep. 2022 Apr;49(4):2755-2763. doi: 10.1007/s11033-021-07087-1. Epub 2022 Jan 28.
4
A Co-Delivery System of Curcumin and p53 for Enhancing the Sensitivity of Drug-Resistant Ovarian Cancer Cells to Cisplatin.姜黄素和 p53 的共递送系统增强耐药卵巢癌细胞对顺铂的敏感性。
Molecules. 2020 Jun 4;25(11):2621. doi: 10.3390/molecules25112621.
5
Intravesical Gene Therapy.膀胱内基因治疗。
Urol Clin North Am. 2020 Feb;47(1):93-101. doi: 10.1016/j.ucl.2019.09.011.
6
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets.膀胱癌中的透明质酸家族:潜在的预后生物标志物和治疗靶点。
Br J Cancer. 2017 Nov 7;117(10):1507-1517. doi: 10.1038/bjc.2017.318. Epub 2017 Oct 3.
7
Virotherapy: cancer gene therapy at last?病毒疗法:癌症基因疗法终于要实现了吗?
F1000Res. 2016 Aug 30;5. doi: 10.12688/f1000research.8211.1. eCollection 2016.
8
Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.姜黄素通过ROS介导的ERK1/2激活增强顺铂在膀胱癌细胞系中的抗肿瘤活性。
Oncotarget. 2016 Sep 27;7(39):63870-63886. doi: 10.18632/oncotarget.11563.
9
Targeting tumor suppressor genes for cancer therapy.靶向肿瘤抑制基因用于癌症治疗。
Bioessays. 2015 Dec;37(12):1277-86. doi: 10.1002/bies.201500093. Epub 2015 Oct 7.
10
Update in Urothelial Carcinoma: Novel Agents and Targeted Therapy.
Am Soc Clin Oncol Educ Book. 2011 Spring;2011:171-176.